POLR2M Antikörper (C-Term)
Kurzübersicht für POLR2M Antikörper (C-Term) (ABIN4889415)
Target
Alle POLR2M (GRINL1A) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- Reacts with humanPOLR2M
-
Aufreinigung
- Purified (protein A)
-
Immunogen
- Synthetic peptide derived from C terminal part of human POLR2M
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
- WB : 1/500 to 1/5 000 - IF : 1/100 to 1/2 000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Must be reconstituted in distilled water.
-
Konzentration
- 1 mg/mL
-
Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Haltbarkeit
- 24 months
-
-
- POLR2M (GRINL1A) (Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate-Like 1A (GRINL1A))
-
Andere Bezeichnung
- POLR2M
-
Hintergrund
- Involved in the Hippo pathway as core protein, it forms a nuclear complex with other TEAD and phosphorylated YAP and TAZ.
-
NCBI Accession
- NP_001018112
-
UniProt
- P0CAP2
Target
-